![Meredith S. Manning](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Meredith S. Manning
Corporate Officer/Principal presso SOLENO THERAPEUTICS, INC.
Profilo
Meredith S.
Manning is currently the Chief Commercial Officer at Soleno Therapeutics, Inc. She previously worked as the Vice President-Global Hemophilia Marketing at Baxter International, Inc. from 2013 to 2015.
She was also the President-Americas at PharmaEssentia Corp.
and the Chief Commercial Officer at resTORbio, Inc. from 2018 to 2019.
Ms. Manning received her undergraduate degree from The Colorado College and her MBA from The University of Chicago Booth School of Business.
Posizioni attive di Meredith S. Manning
Società | Posizione | Inizio |
---|---|---|
SOLENO THERAPEUTICS, INC. | Corporate Officer/Principal | 24/01/2024 |
Precedenti posizioni note di Meredith S. Manning
Società | Posizione | Fine |
---|---|---|
ADICET BIO, INC. | Corporate Officer/Principal | 06/12/2019 |
BAXTER INTERNATIONAL INC. | Vendite & Marketing | 01/07/2015 |
PHARMAESSENTIA CORPORATION | Corporate Officer/Principal | - |
Formazione di Meredith S. Manning
The Colorado College | Undergraduate Degree |
The University of Chicago Booth School of Business | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 3 |
---|---|
BAXTER INTERNATIONAL INC. | Health Technology |
SOLENO THERAPEUTICS, INC. | Health Technology |
PHARMAESSENTIA CORPORATION | Health Technology |
Aziende private | 1 |
---|---|
resTORbio, Inc.
![]() resTORbio, Inc. BiotechnologyHealth Technology resTORbio, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the development and commercialization of medicines for aging-related diseases and conditions. It offers an immunotherapy under the TORC1 program. The company was founded by Chen Schor and Joan Mannick on July 5, 2016 and is headquartered in Boston, MA. | Health Technology |
- Borsa valori
- Insiders
- Meredith S. Manning